A. D. de Jonge

Epcoritamab induces potent anti-tumor activity against malignant B-cells from patients with DLBCL, FL and MCL, irrespective of prior CD20 monoclonal antibody treatment

D. de Jong, T. Mutis, M. Roemer, 2021, Blood cancer journal.

Preclinical activity and determinants of response of the GPRC5DxCD3 bispecific antibody talquetamab in multiple myeloma.

G. Morgan, P. Sonneveld, R. Verona, 2021, Blood advances.

Oral eltanexor treatment of patients with higher-risk myelodysplastic syndrome refractory to hypomethylating agents

E. Baloglu, Sangmin Lee, B. Bhatnagar, 2022, Journal of Hematology & Oncology.

Consolidative thoracic radiotherapy and prophylactic cranial irradiation in limited disease small cell lung cancer.

A. Karim, B. Slotman, K. H. Njo, 1993, Lung cancer.

Hypofractionated radiation therapy in unresectable stage iii non‐small cell lung cancer

A. Karim, B. Slotman, K. H. Njo, 1993, Cancer.